Fluence has already exceeded its full-year 2025 EBITDA after nine months of 2026, but delayed customer decisions have cut order intake and pushed operating cash flow into the red. The ASX-listed water treatment group is betting on a stronger fourth quarter to convert its improving margins into cash and backlog.
- YTD revenue rises 11.3% to US$58.0 million
- YTD EBITDA more than triples to US$4.7 million
- Gross margin expands to 35.2%
- YTD orders fall 20.3% as major awards are delayed
- Cash falls to US$6.7 million, with positive Q4 operating cash flow expected
Fluence passes full-year EBITDA target before Q4
Fluence Corporation Limited (ASX:FLC) has already surpassed its entire FY2025 EBITDA after nine months of 2026, giving the water treatment company a stronger earnings base even as customer investment delays weigh on orders and cash collection.
Unaudited year-to-date revenue reached US$58.0 million, up 11.3% on the prior-year period, while EBITDA more than tripled to US$4.7 million from US$1.4 million. Quarterly EBITDA rose 14.5% to US$1.3 million, extending Fluence’s run to eight consecutive positive quarters. Management expects another positive EBITDA result in Q4, which would make nine in a row.
The improvement is being driven by a deliberate shift towards Smart Product Solutions and recurring revenue. That mix grew 38.5% year on year to add US$12.5 million, while gross margin expanded 6.2 percentage points to 35.2%. Fluence’s first-half performance had already marked its strongest EBITDA result in more than five years, as reported in the strong first-half EBITDA result, and the Q3 figures extend that trajectory rather than reset it.
Delayed awards leave order book under pressure
The weaker part of the update is order momentum. Q3 new orders were US$8.0 million, taking the year-to-date total to US$31.6 million, down 20.3% from the same period in 2025. Fluence said several larger awards were delayed by customer investment decisions, with most described as delayed rather than lost. However, the company no longer expects FY2026 orders to exceed FY2025.
Backlog stood at US$47.1 million at 30 September, down from US$59.8 million at the end of June as revenue was recognised without the delayed awards being replaced. The composition is improving: Smart Product Solutions and recurring revenue represented 98.2% of backlog, compared with 72.8% a year earlier. Recurring-revenue orders themselves rose 68.4% year to date to US$10.3 million.
Management is forecasting its strongest order-booking quarter of the year in Q4. That is an expectation, not a booked outcome, and the distinction matters after the company missed its own Q3 order expectations. Recent wins include a US$2.3 million NIROBOX effluent treatment plant in Saudi Arabia, US$2.0 million of Aspiral MABR wastewater plants for repeat customer iTest, and US$1.3 million of Ivory Coast maintenance services.
Cash conversion becomes the immediate test
Fluence ended September with US$6.7 million in cash and a further US$4.0 million in security deposits, but operating cash flow was negative US$4.3 million for the quarter. The company attributed the shortfall mainly to more than US$5.5 million of delayed receipts tied to Ivory Coast maintenance fees and the Qurayyah water treatment project.
Those payments are expected imminently, alongside a further Ivory Coast Addendum milestone. Fluence expects operating cash flow to turn positive in Q4, although it now says the improvement will be less than originally forecast because of the Q3 order delays. The next quarter therefore has to demonstrate not just profitability on paper, but collection of the receivables that support it.
Ivory Coast project nears completion and O&M decision
The Ivory Coast Addendum project remains scheduled for completion by December 2026. Fluence has collected seven milestone payments worth €42.4 million, or about 87.6% of the contract value, with milestones 8 and 9 worth approximately €6.0 million expected across Q4 2026 and Q1 2027.
The project generated US$6.5 million of EBITDA in the first nine months, helped by strong project margins and contract price adjustments. Fluence is also negotiating a long-term operations and maintenance contract for the plant after September discussions resolved a number of outstanding technical and commercial issues. The earlier Ivory Coast plant progress had been presented as part of Fluence’s move away from large, lower-frequency engineered projects towards recurring services; that contract has not yet been signed.
Egypt exit removes one source of uncertainty
Fluence formally suspended its Egyptian operations on 12 October and is progressing towards liquidation of the business, which will continue to be reported as a discontinued operation. Management is working through remaining contractual and financial obligations while pursuing outstanding receivables.
Against that backdrop, the central Q4 question is whether delayed orders arrive quickly enough to replenish backlog and whether the expected customer receipts convert the company’s improved EBITDA into positive operating cash flow. Fluence’s earnings mix is moving in the desired direction, but the balance sheet still leaves limited room for execution slippage.
Bottom Line?
Fluence’s margin and recurring-revenue gains are tangible, but Q4 must prove that delayed orders and customer receipts can restore backlog and cash generation.
Questions in the middle?
- How much of the delayed Q3 project pipeline will convert into signed Q4 orders?
- Will the expected Ivory Coast and Qurayyah receipts arrive on schedule and lift operating cash flow?
- Can Fluence finalise the long-term Ivory Coast O&M contract before the Addendum project reaches completion?